COVID-19 Delayed Cancer Treatment, Diagnoses
Restrictions in access to care during the COVID-19 pandemic caused disruptions in the treatment and diagnoses of cancer and other conditions.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Cancer, Covid 19 |
Restrictions in access to care during the COVID-19 pandemic caused disruptions in the treatment and diagnoses of cancer and other conditions.
Read MorePosted by Andy Lundin | Nov 22, 2021 | Breast |
The US Food and Drug Administration (FDA) has granted ‘Breakthrough Device Designation’ for Datar Cancer Genetics’ ‘TriNetra’ blood test for breast cancer.
Read MorePosted by Chris Wolski | Nov 10, 2021 | Cancer |
Unemployed individuals are less likely to have health insurance and to be up to date on getting recommended cancer screening tests.
Read MorePosted by Chris Wolski | Nov 9, 2021 | Pancreatic |
Bluestar Genomics’ liquid biopsy test can detect a pancreatic cancer signal in people across various age groups and in patients with new-onset diabetes.
Read MorePosted by Chris Wolski | Oct 4, 2021 | Breast |
Undergoing genetic testing Keri Forsythe-Stephens, learned she had a mutation of the gene, CHEK2, making her more susceptible to breast cancer.
Read More